# Finasteride and brain fog: what is known

Brain fog has been reported with finasteride. Here is what FDA safety reports can tell you, what remains uncertain and why the formulation matters.

Canonical: https://velri.co/blog/finasteride-brain-fog-cognitive-side-effects-hairline
Publisher: Velri (https://velri.co/about)
Published: 2026-07-17
Updated: 2026-09-30
Editorial policy: https://velri.co/editorial-policy

Brain fog has been reported by people using finasteride, including in FDA reports involving compounded topical products. Those reports matter, but they do not establish how often it happens or prove that finasteride caused every reported symptom. [1][2]

## What the FDA has reported

In a 2025 alert, the FDA listed brain fog among adverse events reported after use of compounded topical finasteride. Other reported problems included fatigue, insomnia, anxiety and depression. Some reports described symptoms continuing after treatment stopped. [1]

The FDA states that absorption of topical finasteride into the bloodstream is expected. There is no FDA-approved topical finasteride product. Compounded versions are not FDA approved, and the agency has not evaluated their safety, effectiveness or quality before marketing. [1]

The approved oral product's prescribing information lists depression and suicidal thoughts or behavior in its postmarketing section. It explains that voluntary reports come from a population of uncertain size, which limits estimates of frequency and conclusions about causation. [2]

## Why a symptom timeline helps

“Brain fog” may describe trouble concentrating, slower recall, fatigue or feeling mentally unlike yourself. Writing down the specific change gives the person assessing it more to work with than the label alone.

Useful details include when it began, whether it followed a new medicine or formulation, and what changed in sleep, mood or other medications around the same time. Sleep loss, depression and medicines can contribute to fatigue, so timing is a clue rather than a diagnosis. [3]

A discussion about symptoms should include the exact product and whether it is oral or topical. A safety report about one formulation cannot supply a precise personal risk estimate for another. [1][2]

New symptoms deserve a review of their effect on daily life and the treatment's value to you.

## Sources
[1] FDA alerts health care providers, compounders and consumers of potential risks associated with compounded topical finasteride products | FDA (2025). https://www.fda.gov/drugs/human-drug-compounding/fda-alerts-health-care-providers-compounders-and-consumers-potential-risks-associated-compounded
[2] PROPECIA (finasteride) tablets: prescribing information (2022). https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020788s030lbl.pdf
[3] Fatigue: MedlinePlus Medical Encyclopedia (2025). https://medlineplus.gov/ency/article/003088.htm

## About this information
General health information, not personal medical advice, diagnosis or treatment. A prescription is required and is never guaranteed.
Velri is a brand operated by Velri Management LLC, a Nevada limited liability company. Velri is a non-clinical technology and administrative services company. Velri does not provide medical advice, diagnosis, treatment, or pharmacy services, and does not direct the clinical judgment of any provider.
All medical consultations and prescriptions are provided directly by independent provider groups (Online Medical Care, P.C.; TMD of Kansas, P.A.; TMD of Texas, P.A.; and TMD of CA, PC), by a provider licensed in your state. Velri does not employ providers. A prescription is issued only if a provider determines it is clinically appropriate in their independent medical judgment.
All prescription products are dispensed by independent, licensed pharmacies. Velri does not own, operate, or control any pharmacy and does not dispense medication. You may opt out of using a given provider group or pharmacy at any time.
Compounded medications are not reviewed or approved by the FDA for safety, effectiveness, or quality. Compounded products are not equivalent to or interchangeable with any FDA-approved brand-name drug. Availability varies by state.
Velri is cash-pay. We do not bill Medicare, Medicaid, or commercial insurance. Refunds and order problems are addressed in the Terms of Use; your rights under applicable law are not limited. State availability and clinical eligibility apply.
Velri and telehealth are not for medical emergencies. If you are experiencing an emergency, call 911.
These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
Care is available to eligible adults 18 and older in 47 states and D.C., United States only.
Notice of Privacy Practices: https://velri.co/privacy/notice-of-privacy-practices
Terms: https://velri.co/legal/terms
Provider group or pharmacy opt-out help: https://velri.co/contact and https://velri.co/standards#trust-support